Brief: Grail And Quest Diagnostics Provide Grail's Galleri Multi-Cancer Early Detection (MCED) Test
12/02/2025 14:05
Feb 12 (Reuters) - Quest Diagnostics DGX.N :
* GRAIL AND QUEST DIAGNOSTICS PROVIDE GRAIL'S GALLERI®
MULTI-CANCER EARLY DETECTION (MCED) TEST THROUGH THE QUEST
DIAGNOSTICS TEST ORDERING SYSTEM
Source text: ID:nPn3mmxR8a
Further company coverage: DGX.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grail
See all newsGrail rises as TD Cowen more than doubles PT on FDA, Medicare optimism
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, Tesla
Street View: Grail cancer test's progress boosts prospects for multi-cancer detection market
NASDAQ RESUMED AT 07:05 AM